News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Job Trends
Sanofi-Aventis (France) to Cut 1700 US Jobs
October 8, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- Sanofi Aventis SA, the French company attempting a hostile takeover of Genzyme Corp., will cut 1,700 U.S. pharmaceutical jobs, or 25 percent of its American drug operations, to prepare for acquisitions and patent expirations.
Twitter
LinkedIn
Facebook
Email
Print
Job creations
People
Europe
MORE ON THIS TOPIC
Layoff Tracker
Theravance Halves Headcount, Cans R&D Work After Phase 3 Fail
March 4, 2026
·
61 min read
·
BioSpace Editorial Staff
Job Trends
The Job Market May Be Warming—What Does That Mean for You?
March 4, 2026
·
4 min read
·
Angela Justice
Layoffs
BioAtla Axes 70% of Staff, Explores Strategic Options
March 2, 2026
·
1 min read
·
Angela Gabriel
Special edition
Deep Dive: BioSpace Takes On JPM26 in San Francisco
February 27, 2026
·
2 min read
·
Annalee Armstrong